Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components
10.12997/jla.2024.13.3.306
- Author:
Mi-Bo KIM
1
;
Jaeeun LEE
;
Ji-Young LEE
Author Information
1. Department of Nutritional Sciences, University of Connecticut, Storrs, CT, USA
- Publication Type:Review
- From:Journal of Lipid and Atherosclerosis
2024;13(3):306-327
- CountryRepublic of Korea
- Language:English
-
Abstract:
Dysfunctional mitochondria have been linked to the pathogenesis of obesity-associated metabolic diseases. Excessive energy intake impairs mitochondrial biogenesis and function, decreasing adenosine-5’-triphosphate production and negatively impacting metabolically active tissues such as adipose tissue, skeletal muscle, and the liver. Compromised mitochondrial function disturbs lipid metabolism and increases reactive oxygen species production in these tissues, contributing to the development of insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease. Recent studies have demonstrated the therapeutic potential of bioactive food components, such as resveratrol, quercetin, coenzyme Q10, curcumin, and astaxanthin, by enhancing mitochondrial function. This review provides an overview of the current understanding of how these bioactive compounds ameliorate mitochondrial dysfunction to mitigate obesity-associated metabolic diseases.
